—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
PSYCHOPHARMACOLOGY《精神药理学》
月刊 - 德国
  • PSYCHOPHARMACOLOGY《精神药理学》
  • SCIE外文期刊
  • 期发文量16
  • 国人占比10.42%
  • 维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:2
    环比增速:200.00%
  • 期刊信息

  • 研究方向:医学-NEUROSCIENCES神经科学;PHARMACOLOGY PHARMACY药学;PSYCHIATRY精神病学
  • 国际刊号:ISSN 0033-3158;EISSN 1432-2072
  • 期刊语言:英语
    出版地区:德国
  • 投稿网址:https://www.editorialmanager.com/psph/
  • 电子邮箱:
  • 期刊官网:https://www.springer.com/journal/213/
  • 作者指南:
  • 出版商网址:https://www.springer.com/
  • 出版地址:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004
  • 期刊简介:PSYCHOPHARMACOLOGY《精神药理学》(月刊)。Psychopharmacology is an international journal of research and scholarship, the aims of which are to cover the general area of elucidating the neurochemical mechanisms that affect behavior, all terms understood in the broadest sense. The scope of the Journal extends from clinical psychopharmacology (including trials), to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies (techniques covered) may range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry. The journal is particularly interested in articles that integrate these levels of analysis.

  • 万维提示




  • 1、投稿方式:在线投稿。

    2、官网网址:https://www.springer.com/journal/213/

    3、投稿网址:https://www.editorialmanager.com/psph/

    4、官网邮箱:

    audreystephanie.quibot@springernature.com

    (有关投稿问题,同行评审过程或稿件状态的查询)

    Christian.Abueva@springernature.com

    (有关稿件出版或出版后更正中问题的查询)

    Detlef.Klueber@springer.com

    (有关期刊的任何其他查询或提交前的查询)

    5、期刊刊期:月刊,一个月出版一期。

    2021426日星期一

                                

     

    投稿须知

    【官网信息】

     

    Submission guidelines

    Instructions for Authors

    GENERAL GUIDELINES

    Legal Requirements

    The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of the copyright owners, that the rights of third parties will not be violated, and that the publisher will not be held legally responsible should there be any claims for compensation. For more details, please visit the journal’s website and refer to the section on “Copyright Information” under “For Authors and Editors.”

    Authorship

    Psychopharmacology adheres to the following principles, as set out by The Society for Neuroscience in its guidelines on "Responsible Conduct Regarding Scientific Communication" (http://www.sfn.org/index.cfm?pagename=responsibleConduct): "Authorship should be based on a substantial intellectual contribution.

    Authorship must be reserved for individuals who have met each of the following conditions: (a) made a significant contribution to the conception and design or the analysis and interpretation of data, (b) participated in drafting the article or reviewing and/or revising it for intellectual content, and (c) approved the final version of the manuscript. (Deceased persons deemed appropriate as authors should be so included with a footnote reporting their death.)".

    Permissions

    Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

    Once your paper has been accepted for publication, you will receive per e-mail a link to the "Copyright Transfer Statement," which must be signed and submitted before your paper can be published.

    - - -

    The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.

    Open Choice Publication

    In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular ‘subscription-based’ article, but in addition is made available publicly through Springer’s online platform SpringerLink. We regret that Springer Open Choice cannot be ordered for published articles. For more details, please visit the journal’s website and refer to the section on “Open Choice” under “For Authors and Editors” (http://springer.com/openchoice).

    TYPES OF PAPERS

    The following types of articles may be submitted for publication in the journal:

    Review Articles

    should not exceed 25 pages of text (excluding title page, abstract, references, tables, and figures).

    Original Investigations

    should not exceed 15 pages of text (excluding title page, abstract, references, tables, and figures). It should be noted that Psychopharmacology does not impose a minimum length on original investigations.

    Theoretical and Methodological Perspectives:

    This type of manuscript is primarily intended for critical evaluations of methods and theories, preferably by a consortium of authors from different laboratories. These contributions may also introduce novel theories and methods. Such contributions should be planned in consultation with a Principal Editor. Typically, these contributions are limited to 15 pages of text (excluding title page, abstract, references, tables, and figures) and may contain supplementary video material.

    Letters to the Editor and Commentaries

    are generally in the form of technical comments or points of controversy and should not exceed 3 pages of text.

    ……




欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码